Stratos Wealth Advisors, LLC Bristol Myers Squibb CO Transaction History

Stratos Wealth Advisors, LLC

$2.13 Billion
Q3 2024

A detailed history of Stratos Wealth Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Stratos Wealth Advisors, LLC holds 24,134 shares of BMY stock, worth $1.39 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

24,134

Previous 24,862 2.93%

Holding current value

$1.39 Million

Previous $1.03 Million 20.93%

% of portfolio

0.06%

Previous 0.05%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$39.66 - $51.75 $28,872 - $37,674	-728 Reduced 2.93%	24,134 $1.25 Million
Q2 2024 Jul 24, 2024	SELL	$40.25 - $52.99 $2.23 Million - $2.94 Million	-55,494 Reduced 69.06%	24,862 $1.03 Million
Q1 2024 Apr 16, 2024	SELL	$47.98 - $54.4 $136,023 - $154,224	-2,835 Reduced 3.41%	80,356 $4.36 Million
Q4 2023 Jan 24, 2024	SELL	$48.48 - $57.85 $166,771 - $199,004	-3,440 Reduced 3.97%	83,191 $4.27 Million
Q3 2023 Oct 24, 2023	BUY	$57.89 - $64.73 $191,789 - $214,450	3,313 Added 3.98%	86,631 $5.03 Million
Q2 2023 Jul 18, 2023	SELL	$63.71 - $70.74 $8,346 - $9,266	-131 Reduced 0.16%	83,318 $5.33 Million
Q1 2023 Apr 27, 2023	BUY	$65.71 - $74.53 $42,317 - $47,997	644 Added 0.78%	83,449 $5.78 Million
Q4 2022 Jan 19, 2023	BUY	$68.48 - $81.09 $4.08 Million - $4.83 Million	59,580 Added 256.53%	82,805 $0
Q3 2022 Oct 24, 2022	SELL	$0.13 - $76.84 $2,056 - $1.22 Million	-15,821 Reduced 40.52%	23,225 $1.65 Million
Q2 2022 Jul 22, 2022	BUY	$72.62 - $79.98 $22,439 - $24,713	309 Added 0.8%	39,046 $3.01 Million
Q1 2022 Apr 26, 2022	SELL	$61.48 - $73.72 $171,590 - $205,752	-2,791 Reduced 6.72%	38,737 $2.83 Million
Q4 2021 Jan 14, 2022	BUY	$53.63 - $62.52 $210,712 - $245,641	3,929 Added 10.45%	41,528 $2.59 Million
Q3 2021 Oct 19, 2021	SELL	$59.17 - $69.31 $105,855 - $123,995	-1,789 Reduced 4.54%	37,599 $2.23 Million
Q2 2021 Jul 19, 2021	BUY	$61.91 - $67.42 $177,681 - $193,495	2,870 Added 7.86%	39,388 $2.63 Million
Q1 2021 Apr 27, 2021	BUY	$59.34 - $66.74 $254,271 - $285,980	4,285 Added 13.29%	36,518 $2.31 Million
Q4 2020 Jan 29, 2021	BUY	$57.74 - $65.43 $975,748 - $1.11 Million	16,899 Added 110.21%	32,233 $2 Million
Q3 2020 Oct 29, 2020	SELL	$57.43 - $63.64 $24,637 - $27,301	-429 Reduced 2.72%	15,334 $925,000
Q2 2020 Jul 28, 2020	BUY	$54.82 - $64.09 $110,078 - $128,692	2,008 Added 14.6%	15,763 $927,000
Q1 2020 May 04, 2020	BUY	$46.4 - $67.43 $22,968 - $33,377	495 Added 3.73%	13,755 $767,000
Q4 2019 Jan 29, 2020	SELL	$49.21 - $64.19 $146,596 - $191,222	-2,979 Reduced 18.34%	13,260 $851,000
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $96,018 - $113,843	-2,245 Reduced 12.15%	16,239 $823,000
Q2 2019 Aug 06, 2019	BUY	$44.62 - $49.34 $45,021 - $49,784	1,009 Added 5.77%	18,484 $838,000
Q1 2019 May 07, 2019	BUY	$45.12 - $53.8 $27,297 - $32,549	605 Added 3.59%	17,475 $834,000
Q4 2018 Feb 12, 2019	BUY	$48.76 - $63.23 $822,581 - $1.07 Million	16,870 New	16,870 $877,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Advisors, LLC with notifications on news.

Account

Stratos Wealth Advisors, LLC Bristol Myers Squibb CO Transaction History